background

Filter By Category

Active Pharma Ingredients
Disease Dictionary

Archives

Posted by -

Active Pharma Ingredients / 25 Aug 2026

ANISTREPLASE

Generic Name: ANISTREPLASE

ABSTRACT -

Anistreplase is an anisoylated plasminogen-streptokinase activator complex developed as a thrombolytic agent. After deacylation, the complex activates plasminogen to plasmin, promoting fibrin clot breakdown in acute thrombotic events such as myocardial infarction in historical use.

DOSAGE - 

  • Dosage should be determined only by a qualified healthcare professional.
  • Historical regimens used a single intravenous bolus in acute myocardial infarction settings.
  • Use depends on current availability, regional guidance, and contraindication assessment.
  • Coagulation, bleeding, and reperfusion monitoring are required.

SIDE EFFECTS–

  • Possible side effects include:
  • Bleeding
  • Hypotension
  • Reperfusion arrhythmias
  • Fever
  • Nausea
  • Allergic reactions
  • Injection-site bleeding
  • Intracranial hemorrhage risk

ALLRGIC REACTIONS–

  • Possible allergic reaction symptoms include:
  • Rash
  • Urticaria
  • Bronchospasm
  • Angioedema
  • Anaphylaxis
  • Serum-sickness-like reactions
  • Important: Patients who develop an allergic reaction to Anistreplase should seek immediate medical attention and inform all future healthcare providers of the allergy.

DRUG INTERACTIONS–

  • Anticoagulants and antiplatelet agents increase bleeding risk.
  • NSAIDs may increase bleeding risk.
  • Recent streptococcal exposure or prior streptokinase therapy may affect immune reactions.
  • Other thrombolytics or fibrinolytics must not be combined casually.
  • Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.

PREAUTIONS–

  • Exclude active bleeding, hemorrhagic stroke history, recent major surgery, severe uncontrolled hypertension, and other thrombolysis contraindications.
  • Monitor neurologic status and bleeding sites.
  • Use only in emergency cardiovascular settings.
  • Assess allergy history to streptococcal proteins.

WARNINGS –

  • Fatal bleeding, including intracranial hemorrhage, can occur.
  • Administer only where resuscitation and bleeding management are available.
  • Not for self-administration.
  • Keep out of reach of children.

Have any questions? or Need help Contact us – 022 6163 6163 | support@medicus.com

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2026 Copyright. All rights reserved. Powered by . Developed by Hats-Off

Log in with your credentials

Forgot your details?

Feedback